Intermountain Ventures
United States
- Salt Lake City, Utah
- 16/11/2022
- Series E
- $90,000,000
We partner with early- and growth-stage companies, corporations, venture capital/private equity firms, technology organizations, and mission-based organizations who are leading the charge to improve health.
We work with our clinical teams to identify problems and opportunities to transform care and then scan the market to find those companies that will deliver the greatest impact. We provide access to capital, data and clinical expertise to help these companies grow into scalable solutions that will dramatically improve the delivery of care and health in our communities and the world.
- Industry Venture Capital and Private Equity Principals
- Website https://intermountainventures.com/
- LinkedIn https://www.linkedin.com/company/intermountain-ventures/
Related People
Nickolas MarkInvestor
United States -
Salt Lake City Metropolitan Area
Impact exists in every investment. Put simply, I am relentlessly focused on impact and tackling some of the biggest challenges in healthcare. It is my privilege to partner with early pioneers, creative entrepreneurs, and mission-driven organizations focused on new approaches in realizing meaningful, measurable, and positive change.
Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Lucis (YC X25) | $8,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)